2006
DOI: 10.1016/j.jcv.2006.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 30 publications
(25 citation statements)
references
References 7 publications
1
23
1
Order By: Relevance
“…However, we found the sensitivities of both tests to be slightly lower than reported and the sensitivity of Capillus to be lower than that of Determine (98.6% and 99.3%, respectively). Poor sensitivity has been reported elsewhere in sub-Saharan Africa (1,4). In contrast, we found the sensitivities of the Murex and Uniform II ELISA tests to be 100% and 99.3%, respectively.…”
Section: Discussioncontrasting
confidence: 64%
See 1 more Smart Citation
“…However, we found the sensitivities of both tests to be slightly lower than reported and the sensitivity of Capillus to be lower than that of Determine (98.6% and 99.3%, respectively). Poor sensitivity has been reported elsewhere in sub-Saharan Africa (1,4). In contrast, we found the sensitivities of the Murex and Uniform II ELISA tests to be 100% and 99.3%, respectively.…”
Section: Discussioncontrasting
confidence: 64%
“…Data from a number of evaluations suggest that the sensitivity and specificity of SR tests are similar to those of ELISA-and Western blotting-based algorithms (6,16). However, more recent studies have reported lower-than-expected sensitivities and specificities of SR tests (1,4). Therefore, for use in clinical trials, SR tests should be validated locally and undergo external quality assessment.…”
mentioning
confidence: 99%
“…Specific HIV antibody levels were determined by testing serially double-diluted serum specimens with a rapid assay of known relatively low sensitivity [Claassen et al, 2006], the Capillus TM HIV-1/HIV-2 rapid antibody test (Trinity Biotech plc, Bray Co. Wicklow, Ireland). Samples with a Capillus TM titer of 256 or higher were allocated to the High-Level group and samples with a titer of 4 or less, including falsenegatives, were allocated to the Low-Level group.…”
Section: Laboratory Testingmentioning
confidence: 99%
“…In a previous series [Claassen et al, 2006] two infants who were receiving ART did not have detectable HIV antibodies, even when tested with a laboratory-based third-generation enzyme immunoassay (EIA). The lack of antigenic stimulus due to suppression of retroviral replication through ART could have contributed to the absence of detectable antibodies in these patients [Desai et al, 2005].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation